DGAP-News: Epigenomics AG / Key word(s): Takeover 26.04.2017 / 04:02 The issuer is solely responsible for the content of this announcement. Press release Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG – Shareholders will be offered 7.52 Euros in cash per share valuing Epigenomics at approximately 171 million Euros – The offer reflects […]
Category: Press Releases
26. April 2017
Epigenomics AG: Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG
Read more
26. April 2017
Epigenomics AG Reports Results for Financial Year 2016
DGAP-News: Epigenomics AG / Key word(s): Final Results/Forecast 26.04.2017 / 04:39 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Reports Results for Financial Year 2016 Berlin (Germany) and Germantown, MD (U.S.A.), April 26, 2017 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY), or the “Company”, today announced its financial […]
03. March 2017
Epigenomics AG: U.S. Department of Veterans Affairs awards supply contract for Epi proColon(R)
DGAP-News: Epigenomics AG / Key word(s): Contract 03.03.2017 / 11:40 The issuer is solely responsible for the content of this announcement. Press ReleaseEpigenomics AG: U.S. Department of Veterans Affairs awards supply contract for Epi proColon(R)Berlin (Germany) and Germantown, MD (U.S.A.), March 3, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), today announced that […]
27. February 2017
Epigenomics Joins Forces with hundreds of Organizations to Increase Colorectal Cancer Screening Rates in the United States
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous27.02.2017 / 13:30The issuer is solely responsible for the content of this announcement.—————————————————————————Epigenomics Joins Forces with hundreds of Organizations to IncreaseColorectal Cancer Screening Rates in the United States”80% by 2018″ is a shared goal to have 80% of adults aged 50 and olderscreened for colorectal cancer by 2018 – […]
14. February 2017
Epigenomics AG: Journal of Molecular Diagnosis & Therapy publishes review of blood-based screening test Epi proColon(R) 2.0 CE
DGAP-News: Epigenomics AG / Key word(s): Study 14.02.2017 / 09:45 The issuer is solely responsible for the content of this announcement. Press release Journal of Molecular Diagnosis & Therapy publishes review of blood-based screening test Epi proColon(R) 2.0 CE Liquid biopsy test delivers high sensitivity and specificity and may increase participation in cancer screening programs […]
30. January 2017
Epigenomics AG: Systematic study review supports use of Epi proColon(R) in blood-based cancer detection
DGAP-Media / 30.01.2017 / 10:00 Press release Epigenomics AG: Systematic study review supports use of Epi proColon(R) in blood-based cancer detection Meta-analysis published in renowned journal “Clinical and Translational Gastroenterology” Berlin (Germany) and Germantown, MD (U.S.A.), January 30, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), announced that the scientific results of a […]